DOD Biotech (Thailand) Analysis
| DOD Stock | 2.18 0.04 1.87% |
DOD Biotech Public is overvalued with Real Value of 1.89 and Hype Value of 2.18. The main objective of DOD Biotech stock analysis is to determine its intrinsic value, which is an estimate of what DOD Biotech Public is worth, separate from its market price. There are two main types of DOD Biotech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect DOD Biotech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of DOD Biotech's stock to identify patterns and trends that may indicate its future price movements.
The DOD Biotech stock is traded in Thailand on Thailand Exchange, with the market opening at 10:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Thailand.
DOD |
DOD Stock Analysis Notes
About 48.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.47. Some equities with similar Price to Book (P/B) outperform the market in the long run. DOD Biotech Public last dividend was issued on the 13th of March 2020. To learn more about DOD Biotech Public call Thanin Srisethi at 66 3 444 6333 or check out https://www.dodbiotech.com.DOD Biotech Public Investment Alerts
DOD Biotech Thematic Classifications
In addition to having DOD Biotech stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ITInformation technology and IT services |
DOD Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DOD Biotech's market, we take the total number of its shares issued and multiply it by DOD Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.DOD Profitablity
DOD Biotech's profitability indicators refer to fundamental financial ratios that showcase DOD Biotech's ability to generate income relative to its revenue or operating costs. If, let's say, DOD Biotech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, DOD Biotech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of DOD Biotech's profitability requires more research than a typical breakdown of DOD Biotech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1. Technical Drivers
As of the 24th of November, DOD Biotech shows the Downside Deviation of 2.66, coefficient of variation of 951.52, and Mean Deviation of 2.58. DOD Biotech Public technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.DOD Biotech Public Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. DOD Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for DOD Biotech Public. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
DOD Biotech Predictive Daily Indicators
DOD Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of DOD Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
DOD Biotech Forecast Models
DOD Biotech's time-series forecasting models are one of many DOD Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DOD Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding DOD Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Other Information on Investing in DOD Stock
DOD Biotech financial ratios help investors to determine whether DOD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOD with respect to the benefits of owning DOD Biotech security.